Clovis Oncology, Inc.
CLVS
CLVS was delisted on the 20th of December, 2022.
138 hedge funds and large institutions have $1.31B invested in Clovis Oncology, Inc. in 2014 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 58 increasing their positions, 38 reducing their positions, and 25 closing their positions.
75% more funds holding in top 10
Funds holding in top 10: 4 → 7 (+3)
53% more repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 38
26% more call options, than puts
Call options by funds: $31M | Put options by funds: $24.6M
13% more capital invested
Capital invested by funds: $1.16B → $1.31B (+$147M)
8% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 25
1% less funds holding
Funds holding: 140 → 138 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$34.5M |
| 2 |
PAI
Palo Alto Investors
Palo Alto,
California
|
+$33.7M |
| 3 |
O
OppenheimerFunds
New York
|
+$24.2M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$15.4M |
| 5 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
+$12.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$46.5M |
| 2 |
BBA
Baker Bros. Advisors
New York
|
-$32.8M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$19.3M |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$13M |
| 5 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$11.1M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CCM
151
Cadian Capital Management
New York
| – | -$729K | -17,604 | Closed |
|
152
Two Sigma Advisers
New York
| – | -$530K | -12,806 | Closed |
|
|
NCCM
153
Nine Chapters Capital Management
Short Hills,
New Jersey
| – | -$530K | -12,800 | Closed |
|
154
AQR Capital Management
Greenwich,
Connecticut
| – | -$475K | -11,466 | Closed |
|
|
QT
155
Quantbot Technologies
New York
| – | -$420K | -10,150 | Closed |
|
156
Group One Trading
Chicago,
Illinois
| – | -$278K | -6,666 | Closed |
|
|
TAM
157
Tocqueville Asset Management
New York
| – | -$174K | -4,200 | Closed |
|
|
ARC
158
Absolute Return Capital
Boston,
Massachusetts
| – | -$142K | -3,431 | Closed |
|
|
VFA
159
Virtus Fund Advisers
Hartford,
Connecticut
| – | -$87K | -2,105 | Closed |
|
|
GSC
160
Ground Swell Capital
Folly Beach,
South Carolina
| – | -$39K | -950 | Closed |
|
161
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$19K | -450 | Closed |
|
|
SEC
162
Seven Eight Capital
New York
| – | -$8K | -200 | Closed |
|
163
Creative Planning
Overland Park,
Kansas
| – | -$4K | -100 | Closed |
|
CLVS Hedge Fund Activity: Q3 2014 in Review
138 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Clovis Oncology, Inc. (CLVS) for Q3 2014, worth a combined $1.31B — up 13% from $1.16B a quarter earlier.
Sellers outnumbered buyers: 25 funds closed out of CLVS and 23 opened new positions — a net loss of 2 holders — while 38 trimmed existing stakes and 58 added.
The largest buyer was PFM Health Sciences, adding an estimated $34.5M. The largest seller was Fidelity Investments, cutting an estimated $46.5M.
- 138 institutional investors held Clovis Oncology, Inc. (CLVS) as of Q3 2014, down from 140 in Q2 2014.
- Funds reported $1.31B of Clovis Oncology, Inc. stock for Q3 2014, up 13% quarter-over-quarter.
- 23 funds opened new Clovis Oncology, Inc. positions in Q3 2014 and 25 closed out, a net change of -2 holders.
- The largest Clovis Oncology, Inc. buyer in Q3 2014 was PFM Health Sciences, an estimated $34.5M added.
- The largest Clovis Oncology, Inc. seller in Q3 2014 was Fidelity Investments, an estimated $46.5M sold.
Based on aggregated 13F filings for Q3 2014.